News

CPhA welcomes the decision by Health Canada to revise the federal prescription status of naloxone, a medication that has the potential to significantly reduce the frequency of deaths that occur with opioid overdosage.

As primary care professionals who see patients regularly, pharmacists can play an important role in the care of patients with various forms of dementia.

New national survey of Canadians shows deep trust in pharmacist profession and appreciation for positive impact on health outcomes.

According to a study commissioned by CPhA, governments could  provide relief to the roughly 10% of Canadians who are not covered, or have inadequate coverage, through private or public drug plans by investing up to $2.15 billion a year in a pan-Canadian pharmacare solution

March is Pharmacist Awareness Month in Canada, a month long period to celebrate and educate Canadians about the contribution that pharmacists make in the delivery of health care.

CPhA  today called on governments to ensure that any legislative and regulatory framework for assisted dying in Canada balances the freedom of conscience for pharmacists and a patient's right to access.

CPhA welcomes the announcement today to restore the Interim Federal Health Program to provide full health care coverage to all refugees and asylum claimants.

CPhA CEO Perry Eisenschmid appeared before the House of Commons Finance Committee pre-budget consultations to present CPhA recommendations for the 2016 federal budget.